Daxor Company Insiders
DXR Stock | USD 8.18 0.02 0.25% |
Daxor's insiders are aggressively buying. The analysis of insiders' sentiment of trading Daxor stock suggests that virtually all insiders are extremely bullish at this time. Daxor employs about 16 people. The company is managed by 16 executives with a total tenure of roughly 150 years, averaging almost 9.0 years of service per executive, having 1.0 employees per reported executive.
Michael Feldschuh CEO Interim CEO, Interim President, Head of Bus. Devel. and Strategic Initiatives and Director |
Insider Sentiment 100
Aggressively Buying
Selling | Buying |
Latest Trades
2025-03-10 | Robert J Michel | Acquired 1000 @ 8 | View | ||
2024-03-27 | Robert J Michel | Acquired 750 @ 8.7 | View |
Monitoring Daxor's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Daxor |
Daxor's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Daxor's future performance. Based on our forecasts, it is anticipated that Daxor will maintain a workforce of slightly above 50 employees by April 2025.Daxor Management Team Effectiveness
The company has Return on Asset of (0.0251) % which means that on every $100 spent on assets, it lost $0.0251. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0154 %, implying that it generated $0.0154 on every 100 dollars invested. Daxor's management efficiency ratios could be used to measure how well Daxor manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/16/2025, Return On Equity is likely to grow to 0.02, while Return On Tangible Assets are likely to drop 0.01. At this time, Daxor's Total Assets are relatively stable compared to the past year. As of 03/16/2025, Non Current Assets Total is likely to grow to about 42.1 M, while Non Currrent Assets Other are likely to drop (38.4 M).As of 03/16/2025, Net Income Applicable To Common Shares is likely to grow to about 4.9 M, while Common Stock Shares Outstanding is likely to drop slightly above 3.8 M.
Daxor Workforce Comparison
Daxor is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 14,114. Daxor adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Daxor Profit Margins
The company has Net Profit Margin of 4.48 %, which may imply that it executes well on its competitive polices and has reasonable control over its expenses and variable costs. This is considered to be average in the sector. In the same way, it shows Net Operating Margin of (23.69) %, which entails that for every $100 of revenue, it lost $23.69.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.83 | 0.74 |
|
|
Daxor Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Daxor insiders, such as employees or executives, is commonly permitted as long as it does not rely on Daxor's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Daxor insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2023-09-01 | 8.0 | 8 | 1 | 81,500 | 25,000 |
2018-09-01 | 1.0 | 1 | 1 | 1,500 | 1,000.00 |
2017-03-01 | 1.0 | 2 | 2 | 246,400 | 48,500 |
2016-06-01 | 8.0 | 8 | 1 | 193,100 | 48,500 |
2015-06-01 | 1.0 | 1 | 1 | 300.00 | 1,000.00 |
2013-12-01 | 6.0 | 6 | 1 | 1,584 | 0.00 |
2010-06-01 | 3.0 | 3 | 1 | 6,500 | 0.00 |
2008-12-01 | 1.2857 | 9 | 7 | 3,816 | 3,000 |
2004-06-01 | 0.375 | 3 | 8 | 10,200 | 47,600 |
Daxor Notable Stakeholders
A Daxor stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Daxor often face trade-offs trying to please all of them. Daxor's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Daxor's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Michael Feldschuh | Interim CEO, Interim President, Head of Bus. Devel. and Strategic Initiatives and Director | Profile | |
Robert Michel | Chief Financial Officer | Profile | |
James Lombard | Independent Director | Profile | |
Bernhard Saxe | Independent Director | Profile | |
Robert Willens | Independent Director | Profile | |
Jonathan Feldschuh | Chief Scientific Officer, Director | Profile | |
Martin Wolpoff | Independent Director | Profile | |
Edward Feuer | Director | Profile | |
CPA CPA | Chief CFO | Profile | |
Joy Goudie | Independent Director | Profile | |
Jean Oertel | Senior Experience | Profile | |
Guido Manzo | Vice Sales | Profile | |
Henry Cremisi | Director | Profile | |
Kathryn Kornafel | Senior Development | Profile | |
FACC MBA | Chief Officer | Profile | |
Linda Cooper | Vice Operations | Profile |
About Daxor Management Performance
The success or failure of an entity such as Daxor often depends on how effective the management is. Daxor management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Daxor management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Daxor management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.01 | 0.01 | |
Return On Capital Employed | (0.03) | (0.03) | |
Return On Assets | 0.01 | 0.01 | |
Return On Equity | 0.01 | 0.02 |
Daxor Workforce Analysis
Traditionally, organizations such as Daxor use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Daxor within its industry.Daxor Manpower Efficiency
Return on Daxor Manpower
Revenue Per Employee | 133.2K | |
Revenue Per Executive | 133.2K | |
Net Income Per Employee | 33.5K | |
Net Income Per Executive | 33.5K | |
Working Capital Per Employee | 2M | |
Working Capital Per Executive | 2M |
Additional Tools for Daxor Stock Analysis
When running Daxor's price analysis, check to measure Daxor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daxor is operating at the current time. Most of Daxor's value examination focuses on studying past and present price action to predict the probability of Daxor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daxor's price. Additionally, you may evaluate how the addition of Daxor to your portfolios can decrease your overall portfolio volatility.